Community-reported Kefral side effects:
Add Your Side Effect to the Community Database
Help Community - Describe Your Kefral Side Effect Episode
Have You dealt with a Kefral side effect? Share your experience
Review Kefral Safety Reports submitted to FDA
Total Kefral reports: 5.Kefral FDA safety alerts: No.
Reported deaths: 3 Reported hospitalizations: 2.
Take Kefral Side Effects Survey, Discuss Kefral with others
FDA Reported Kefral Side Effects: liver disorder, jaundice, gamma-glutamyltransferase increased, enterococcal infection, culture urine positive, atrial fibrillation, aspartate aminotransferase increased, alanine aminotransferase increased, thrombotic thrombocytopenic purpura, lymphocyte stimulation test positive, emphysematous cholecystitis.
More About Kefral.
If you have questions about Kefral, you can ask a Health Expert or Ask Patient Community about Kefral.
Kefral Side Effects Report #5646909-2
Physician from JAPAN reported KEFRAL problem on Feb 25, 2008. Male patient was diagnosed with otitis media, bronchial disorder, sputum retention, rhinorrhoea and was treated with KEFRAL. After drug was administered, patient experienced the following problems/side effects: hepatitis fulminant, liver transplant, multi-organ failure. KEFRAL dosage: 210 MG, DAILY (1/D). During the same period patient was treated with VENETLIN, ASVERIN, MUCOSOLATE, PERIACTIN. Patient died.
Kefral Side Effects Report #5688229-6
KEFRAL problem was reported by a Physician from JAPAN on Dec 26, 2007. Male patient was diagnosed with otitis media, bronchial disorder, sputum retention, rhinorrhoea and was treated with KEFRAL. After drug was administered, patient experienced the following problems/side effects: hepatitis fulminant. KEFRAL dosage: 210 MG, DAILY (1/D). During the same period patient was treated with VENETLIN, ASVERIN, MUCOSOLATE, PERIACTIN. Patient died.
Kefral Side Effects Report #5612757-2
Physician from JAPAN reported KEFRAL problem on Jan 24, 2008. Male patient was diagnosed with otitis media, bronchial disorder, sputum retention, rhinorrhoea and was treated with KEFRAL. After drug was administered, patient experienced the following problems/side effects: hepatitis fulminant. KEFRAL dosage: 210 MG, DAILY (1/D). During the same period patient was treated with VENETLIN, ASVERIN, MUCOSOLATE, PERIACTIN. Patient died.
Kefral Side Effects Report #5383274-2
KEFRAL problem was reported by a Physician from JAPAN on July 04, 2007. Male patient, 57 years of age, was diagnosed with tooth infection and was treated with KEFRAL. After drug was administered, patient experienced the following problems/side effects: emphysematous cholecystitis, thrombotic thrombocytopenic purpura. KEFRAL dosage: unknown. During the same period patient was treated with MEFENAMIC ACID. Patient was hospitalized. Patient recovered.
Kefral Side Effects Report #5383274-2
Physician from JAPAN reported KEFRAL problem on July 04, 2007. Male patient, 57 years of age, was diagnosed with tooth infection and was treated with KEFRAL. After drug was administered, patient experienced the following problems/side effects: emphysematous cholecystitis, thrombotic thrombocytopenic purpura. KEFRAL dosage: unknown. During the same period patient was treated with MEFENAMIC ACID. Patient was hospitalized. Patient recovered.